PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
PRECIGEN, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$6.66+0.28 (+4.31%)
Close on Oct 19, 2026
- Market cap
- $2.76B
- P/E (TTM)
- –
- Dividend yield
- –
Precigen statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Precigen | Industry median |
|---|---|---|
| Market Cap | $2.38B | $166.30M |
| Enterprise Value | $2.44B | $88.19M |
| PB Ratio | 54.72 | 2.03 |
| P/TBV Ratio | 92.43 | 2.29 |
Income (trailing twelve months)
| Measure | Precigen | Industry median |
|---|---|---|
| Net Income | -$157.71M | -$22.46M |
| EPS (Diluted) | -$1.10 | -$0.83 |
Returns
| Measure | Precigen | Industry median |
|---|---|---|
| Return on Equity (ROE) | -4640.4% | -53.2% |
| Return on Assets (ROA) | -115.9% | -40.9% |
Growth
| Measure | Precigen | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -28.9% | 2.25% |
| Revenue Growth (5Y CAGR) | -21.3% | 6.48% |
Balance sheet
| Measure | Precigen | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $38.70M | $61.43M |
| Total Debt | $93.88M | $118.52M |
| Net Cash (Debt) | -$55.18M | $15.35M |
| Net Cash Per Share | -$0.15 | $0.66 |
| Equity (Book Value) | $43.58M | $49.09M |
| Book Value Per Share | $0.12 | $1.37 |
| Tangible Book Value | $25.80M | $23.52M |
| Working Capital | $105.03M | $76.81M |
Financial position
| Measure | Precigen | Industry median |
|---|---|---|
| Current Ratio | 4.58 | 3.34 |
| Quick Ratio | 3.77 | 2.44 |
| Debt / Equity | 2.15 | 0.52 |
Cash flow (trailing twelve months)
| Measure | Precigen | Industry median |
|---|---|---|
| Operating Cash Flow | -$114.17M | -$12.35M |
| Capital Expenditures | -$1.06M | -$1.08M |
| Free Cash Flow | -$115.22M | -$20.22M |
| FCF Per Share | -$0.32 | -$0.42 |
Efficiency
| Measure | Precigen | Industry median |
|---|---|---|
| Profits Per Employee | -$7.89M | -$703.34K |
| Employee Count | 20 | 74 |
Dividends and yields
| Measure | Precigen | Industry median |
|---|---|---|
| Earnings Yield | -6.61% | -23.3% |
| FCF Yield | -4.83% | -8.72% |
| Buyback Yield | 0.00% | -0.59% |
| Shareholder Yield | 0.00% | 0.00% |
Shares
| Measure | Precigen | Industry median |
|---|---|---|
| Shares Outstanding | 358,035,000 | 58,127,000 |
| Shares Change (YoY) | 23.3% | 10.9% |
| Shares Change (QoQ) | 0.59% | 0.54% |
| Float | 197,189,000 | 49,136,700 |
| Shares Held by Insiders | 44.9% | 11.6% |
| Shares Held by Institutions | 39.2% | 59.4% |
Taxes
| Measure | Precigen | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | Precigen | Industry median |
|---|---|---|
| Altman Z-Score | -7.12 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Precigen's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.